Delivery Order SPE2DB22D3009-SPE2DB25FAW17

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,144.96 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,914,073 units of Sumatriptan 6 mg/0.5 mL autoinjectors to support military healthcare programs. The contract has an ultimate completion date of January 14, 2025 and was awarded on January 13, 2025. There is no set-aside designation indicated for this award. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,908,317 units of Sumatriptan 6 mg/0.5 mL autoinjectors. The contract has a ceiling value of $4,986.48 and runs through April 15, 2025. The contract is a Firm Fixed Price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the federal government. The $3,313.16 firm fixed price contract is for the delivery of 4,565,333,175 units of Sumatriptan 6 mg/0.5 ml autoinjector 0.5 ml, with a completion date of August 5, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of 4,564,792,480 units of Sumatriptan 6 mg/0.5 mL autoinjector 0.5 mL, with a ceiling value of $4,073.71 and a period of performance through June 4, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,566,817,288 units of the pharmaceutical drug Sumatriptan 6 mg/0.5 mL auto-injector. The contract has a ceiling value of $2,068.86 and a completion date of January 2, 2025. It is a Firm Fixed Price delivery order contract with no set-aside designation, indicating open competition....
This is a $8,211.43 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is to provide 4,564,881,322 units of the medication Sumatriptan 6 mg/0.5 ml autoinjector, 0.5 ml. The contract has a completion date of June 12, 2024 and was awarded on June 11, 2022. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical and a $750,000 IDC with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Sumatriptan 6 mg/0.5 ml autoinjectors. The $2,909.89 firm-fixed-price contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a wide range of medical commodities to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,407,947 units of Sumatriptan 6 mg/0.5 mL autoinjectors, a medication used to treat migraine headaches. The contract has a ceiling value of $3,883.20 and an ultimate completion date of November 13, 2024. The contract is not designated with a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,768,206 units of Sumatriptan 6 mg/0.5 ml autoinjectors. The award has a ceiling value of $1,893.37 and a completion date of April 2, 2025. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,531,299 units of Sumatriptan 6 mg/0.5 ml autoinjectors. The contract has a ceiling value of $4,285.08 and is a firm fixed price delivery order. The contract has a performance period ending on March 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB25FAW17
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $18,818.98, is for the provision of 4,568,060,909 units of the pharmaceutical product Sumatriptan 6 mg/0.5 mL autoinjector. The contract has an ultimate completion date of April 29, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026, positioning the company as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/28/25, 11:08 AM